From a Single Room to a
Global Healthcare Benchmark

In 2018, inside a modest, single-room office tucked away in Mohali, two passionate visionaries—Dr. Upendra Jain and Ms. Veena Kanwar—decided to challenge the status quo of pharmaceutical consulting. There were no deep institutional funds or safety nets, just an unyielding belief in precision science, relentless work ethic, and transparent client partnerships.

From dawn until late into the night, they analyzed raw toxicology literature, parsed complex regulatory requirements, and crafted reports that placed patient safety and compliance above all else. This formed our foundational philosophy: a "Perfect Blend of Quality and Economy."

Our growth was never rushed; it was organic and demand-driven. As client partnerships matured, their challenges expanded. Clients began asking: "Can Indivirtus help us with our laboratory calibration? Can you handle our pharmacovigilance? Can you engineer our compliant manufacturing facility?"

Rather than subcontracting or providing half-measures, Indivirtus built specialized in-house divisions: setting up NABL-accredited precision calibration labs, establishing 24/7 global Pharmacovigilance desks (ICSR, PSUR/PBRER, signal management), and delivering end-to-end Greenfield & Brownfield turnkey pharmaceutical engineering consulting.

Today, Indivirtus stands tall as a multinational scientific partner. With over 100+ multidisciplinary scientists, toxicologists, engineers, and regulatory specialists spread across 5 international hubs and 4 strategic centers in India, we safeguard drug quality across 64+ countries.

Yet despite global accolades, our heart remains right where it began in 2018: driven by curiosity, guided by ethical rigor, and dedicated to elevating human health. Success to us is not just revenue or reach—it is the millions of patients protected by safe, compliant medicine.